Matching DNA to a diet doesn’t work: ‘We didn’t even come close,’ researcher says
By Sharon Begley, STAT | 02. 20. 2018
DNA testing won’t guide dieters to the weight-loss regimen most likely to work for them, scientists reported on Tuesday. Despite some earlier studies claiming that genetic variants predict whether someone has a better chance of shedding pounds on a low-carbohydrate or a low-fat diet, and despite a growing industry premised on that notion, the most rigorous study so far found no difference in weight loss between overweight people on diets that “matched” their genotype and those on diets that didn’t.
The findings make it less likely that genetics might explain why only some people manage to lose weight on a low-carb diet like Atkins and why others succeed with a low-fat one (even though the vast majority of dieters don’t keep off whatever pounds they lose). Unlike cancer treatments, diets can’t be matched to genotype, the new study shows.
The results underline “how, for most people, knowing genetic risk information doesn’t have a big impact,” said Timothy Caulfield, of the University of Alberta, a critic of quackery. “We know weight loss is tough and sustained weight loss is even...
Related Articles
In 2004, Voters approved Proposition 71 by nearly 60 percent establishing a $3 billion bond to fund the science of stem cell therapy. As a result, the California Institute for Regenerative Medicine, or CIRM, was created to manage the funds...
On August 13, 2018, Molecular Therapy published a report (Open Access) that explicitly “suggests the efficiency and genetic safety of correcting a Marfan syndrome (MFS) pathogenic mutation in embryos by base editing.” That is, another step toward the plausible possibility of germline intervention: heritable human genetic modification.
You’d think this would be a big deal. After all, the Nuffield Council in the UK just published a 200-page evaluation of possible germline intervention, treating it as a future...
On July 17, the UK’s Nuffield Council on Bioethics released “Genome Editing and Human Reproduction: Social and Ethical Issues.” The nearly 200-page report wrapped up several years of work for the ethics think tank that began with their initial 2016 inquiry into human genome editing and included a heavily criticized public consultation process in 2017. The report’s main conclusion regarding human germline modification was that it “could be ethically acceptable in some circumstances.” Karen Yeung, chair of the...
By Daniel Engber, Slate | 07.31.2018
On May 18, W. French Anderson, known as the “father of gene therapy,” was released from prison on parole. Two weeks later, the 81-year-old scientist, pediatrician, and ex-con welcomed science writer Sharon Begley to his home in California for several...
